PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
02-Jun-2021 Global Generic Drugs Market Research Report 2021-2030 - ResearchAndMarkets.com Businesswire
02-Jun-2021 Investigation Report on China's Osimertinib Market 2021-2025: A Small Molecule Targeted Anti-tumor Drug Used to Treat Non-small Cell Lung Cancer (NSCLC) - ResearchAndMarkets.com Businesswire
02-Jun-2021 Can-Fite To Initiate Phase IIb NASH Study with its Drug Candidate Namodenoson Businesswire
02-Jun-2021 MorphoSys to Acquire Constellation Pharmaceuticals Businesswire
02-Jun-2021 Aragen (Formerly GVK BIO) to Partner With Global Biopharma With a Renewed Brand Promise Businesswire
02-Jun-2021 BIOVECTRA Inc. Looks Inward for New Brand: It’s All About Care Businesswire
02-Jun-2021 UNICEF and Moderna Announce Long Term Agreement to Supply Vaccine on Behalf of the COVAX Facility Businesswire
02-Jun-2021 Virios Therapeutics Presents Phase 2a Fibromyalgia Trial Data on Efficacy Analyses of Key Secondary Endpoints at the EULAR European Congress of Rheumatology Businesswire
02-Jun-2021 Kezar Presents Results of the Completed MISSION Phase 1b Study of KZR-616 at EULAR 2021 Businesswire
02-Jun-2021 As ASCO 2021 Spotlights Biomarkers, New InCrowd Data Shows 80% of US Oncologists Anticipate Broader Liquid Biomarkers Use, Despite Insurance Barriers Businesswire
02-Jun-2021 AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses Businesswire
02-Jun-2021 Can-Fite to Present at BIO Digital International Convention & Conduct One-on-One Meetings with Potential Partners on June 10-18, 2021 Businesswire
02-Jun-2021 Lyra Therapeutics and LianBio Announce Strategic Partnership and Exclusive License Agreement to Develop and Commercialize LYR-210 in Greater China and Other Asian Markets Businesswire
02-Jun-2021 Bristol Myers Squibb Receives European Commission Approval for Opdivo (nivolumab) Plus Yervoy (ipilimumab) as First-Line Treatment for Unresectable Malignant Pleural Mesothelioma Businesswire
02-Jun-2021 Bristol Myers Squibb Data at EULAR 2021 Highlight Commitment to Driving Advancements Across Multiple Immune-Mediated Rheumatic Diseases Businesswire
02-Jun-2021 Sunnova Launches Solar + Storage Lease Service Offerings in Nine States Businesswire
02-Jun-2021 Janssen presenta nuevos datos de cilta-cel, una CAR-T dirigida a BCMA, que muestran respuestas profundas y duraderas en pacientes con mieloma múltiple recidivante o refractario Businesswire
02-Jun-2021 Global Cell Therapy Bioprocessing Market Forecast to 2028 - COVID-19 Impact and Analysis by Technology, Cell Type, End User, and Geography - ResearchAndMarkets.com Businesswire
02-Jun-2021 Janssen meldet neue Daten für die gegen das BCMA gerichtete CAR-T-Therapie Cilta-cel, die ein tiefes und dauerhaftes Ansprechen bei Patienten mit rezidiviertem oder refraktärem multiplem Myelom zeigen Businesswire
02-Jun-2021 Janssen rapporte de nouvelles données pour le ciltacabtagène autoleucel (cilta-cel), une thérapie expérimentale à cellules CAR-T ciblant l'antigène de maturation des cellules B (BCMA), illustrant des réponses approfondies ... Businesswire